Maria I. Garcia-Del Olmo

Valencia, VC 46026, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Clinical Presentation and Outcomes of Sporadic Neuroendocrine Neoplasms in Young Adults.

Clinical Presentation and Outcomes of Sporadic Neuroendocrine Neoplasms in Young Adults.

Journal: European journal of endocrinology

Published: February 17, 2026

Primary hepatic gastrinoma as a clinical mimic: Favorable clinical outcomes.

Primary hepatic gastrinoma as a clinical mimic: Favorable clinical outcomes.

Journal: Endocrinologia, diabetes y nutricion

Published: October 27, 2025

Patterns of response and survival in metastatic paragangliomas and pheochromocytomas: Experience from two Spanish neuroendocrine tumor centers.

Patterns of response and survival in metastatic paragangliomas and pheochromocytomas: Experience from two Spanish neuroendocrine tumor centers.

Journal: Journal of neuroendocrinology

Published: July 08, 2025

CXCR4: From Signaling to Clinical Applications in Neuroendocrine Neoplasms.

CXCR4: From Signaling to Clinical Applications in Neuroendocrine Neoplasms.

Journal: Cancers

Published: April 12, 2024

Impact of Diabetes Mellitus in Patients with Pancreatic Neuro-Endocrine Tumors: Causes, Consequences, and Future Perspectives.

Impact of Diabetes Mellitus in Patients with Pancreatic Neuro-Endocrine Tumors: Causes, Consequences, and Future Perspectives.

Journal: Metabolites

Published: October 24, 2022

Same-day comparative protocol PET/CT-PET/MRI [68 Ga]Ga-DOTA-TOC in paragangliomas and pheochromocytomas: an approach to personalized medicine.

Same-day comparative protocol PET/CT-PET/MRI [68 Ga]Ga-DOTA-TOC in paragangliomas and pheochromocytomas: an approach to personalized medicine.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: October 10, 2022

Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review.

Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review.

Journal: Frontiers in endocrinology

Published: May 30, 2022

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma.

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma.

Journal: Nature communications

Published: May 05, 2022

Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions.

Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions.

Journal: Cancers

Published: December 10, 2021

Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms.

Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms.

Journal: Biomedicines

Published: October 29, 2021

[177Lu]Lu-DOTA-TATE and [131I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center.

[177Lu]Lu-DOTA-TATE and [131I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center.

Journal: Frontiers in endocrinology

Published: September 16, 2021

Use of healthcare REsources and associated COsts in controlled versus uncontrolled carcinoid SYndrome in patients with neuroendocrine tumours: the RECOSY study.

Use of healthcare REsources and associated COsts in controlled versus uncontrolled carcinoid SYndrome in patients with neuroendocrine tumours: the RECOSY study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 22, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026